 gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels by unknown
POSTER PRESENTATION Open Access
MEFV gene methylation pattern analysis in
familial Mediterranean fever patients with altered
expression levels
YZ Akkaya Ulum1*, B Balci Peynircioglu1, ED Batu2, C Guler1, O Karadag3, AI Ertenli3, S Kiraz3, S Ozen2, E Yilmaz1
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
Familial Mediterranean Fever (FMF) is caused by mutations
in the MEFV (Mediterranean FeVer) gene, which encodes
pyrin. Phenotypic heterogeneity is very common in FMF
patients and may partly rely on genetic heterogeneity. How-
ever, many cases having weak phenotypic-genotypic corre-
lation, different clinical findings and therapeutic approaches
with the same genotype show that FMF is not a simple
monogenic disorder. Thus we hypothesized that possible
epigenetic factors such as; DNA methylation, post-tran-
scriptional histone modifications and microRNAs may con-
tribute to disease phenotype in FMF patients and decided
to analyze MEFV gene expression and compare the levels
according to DNA methylation status in neutrophils.
Objectives
To better understand the complexity underlying disease
phenotype in FMF by the analysis of DNA methylation
patterns in neutrophils and to find possible mutations in
MEFV mRNA that can be related with the phenotypic het-
erogeneity in patients.
Patients and methods
Blood samples were collected from 6 controls, 6
M694V/M694V patients, 6 M694V/- patients, and 6
M694V/- carriers. Neutrophil cells were isolated with
Lympholyte-poly solution, Cedarlane. RNA and DNA
molecules were extracted from neutrophil cells. qPCR
was performed to measure MEFV gene expression levels
in different individuals. For methylation analysis, DNA
was treated with bisulfite by using EZ DNA Methyla-
tion-Lightning Kit, D5030, Zymo Research. Bisulfite
treated DNA was amplified with special designed bisul-
phite primers that were specific to promoter region of
the MEFV gene. DNA sequencing was performed in
order to calculate the percentage of the methylation.
Results
According to qPCR analysis, decrease in MEFV gene
expression was more in homozygote group (0.12, pC and
L57L were found in MEFV promoter region and exon 1,
respectively (published in Infevers database). Then MEFV
gene promoter region is analyzed by bisulfite sequencing
in different individuals. There were no difference between
patients and healthy group by means of the methylation
pattern at the promoter region that we analyzed.
Conclusion
Based on the results of this study, methylation pattern at
the promoter region may not be the cause of heteroge-
neity for our patients with different clinical phenotype.
Therefore other epigenetic mechanisms that may con-
trol MEFV expression remain to be studied.
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